Global and China Hemodialysis Industry Report, 2011-2012
  • Mar/2012
  • Hard Copy
  • USD $2,000
  • Pages:80
  • Single User License
    (PDF Unprintable)       
  • USD $1,900
  • Code: HK009
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,000
  • Hard Copy + Single User License
  • USD $2,200
      
Hemodialysis is a blood purification technology mainly used for the treatment of end-stage renal disease (ESRD) patients. The global hemodialysis population grew at a CAGR of over 9% in 1990-2010, reaching 2.029 million in 2010. Due to the high cost, the dialysis population is principally concentrated in developed regions such as Europe and the United States. In 2011, the United States, Europe Union and Japan accounted for over 50% of the global dialysis population.

The dialysis population is relatively small in developing countries, but has been growing fast. In the last decade, the number of dialysis patients in China, India and Brazil rose at a rate of more than 15%, far higher than 3%-5% in Europe and the United States. Moreover, barely 10% of ESRD patients are on hemodialysis in developing countries, much lower than 80% in Europe and the United States. Along with the expansion of health insurance coverage and the rise in national income in developing countries, the number of dialysis patients is expected to grow rapidly in a relatively long period.

The hemodialysis industry is composed of hemodialysis service and hemodialysis equipment sectors, with the ratio of market size maintaining 5.2:1 in 2010-2011. In 2010, the global market size of hemodialysis service approximated USD58.8 billion, mainly concentrated in developed regions like North America, Europe and Japan. The hemodialysis service is principally provided by public institutions in Europe, but by private agencies in the U.S. and Japan. Presently, the global leading providers of hemodialysis service include Fresenius Medical Care, DaVita and Kuratorium which served a total of 350,000 dialysis patients in 2010.

The global hemodialysis equipment market features a high concentration ratio and is mainly occupied by European and American enterprises. In 2010, the global top 3 dialysis equipment manufacturers were German Fresenius Medical Care, American Baxter and Swedish Gambro.

Fresenius Medical Care is the world’s largest provider of hemodialysis equipment and service. As of the end of 2011, it set up 2,898 dialysis centers and served 233,000 patients with renal disease. Baxter, the world’s largest manufacturer of peritoneal dialysis equipment, accounted for 72% of the peritoneal dialysis market share in 2010.

China witnesses the mounting demand for hemodialysis therapy, and made up around 7.4% of the global hemodialysis population in 2011. Because of technical backwardness, hemodialysis equipment in China mainly relies on imports. The products imported from companies including Fresenius Medical Care and Gambro occupied up to 80% of the hemodialysis equipment in the Chinese market.

The major domestic hemodialysis equipment manufacturers include Weigao Holding, Jiangsu Lengthen Life Science and Technology, and Jihua Medical Apparatus and Instruments which have greatly improved their product technology and quality, but not competitiveness, and have difficulty in entering the domestic key hospitals (especially third-level and first-class hospitals). However, some of their products have been exported to Saudi Arabia, Indonesia and Cuba.

It is in the report that covers the followings.
20120114.gif The number of hemodialysis patients and distribution in the world;

20120114.gif Status quo, competition and development trend of global hemodialysis equipment and service market;

20120114.gif Market size, competitive landscape and forecast of Chinese hemodialysis industry;

20120114.gif Import & export volume, value, countries or regions of Chinese hemodialysis equipment;

20120114.gif Current situation and competition structure of global and China hemodialysis equipment market segments;

20120114.gif Operation, development prospects and advantages of major hemodialysis product providers at home and abroad.
1. Overview of Hemodialysis Industry
1.1 Definition
1.2 Hemodialysis Device
1.3 Hemodialysis Service
1.3.1 In-center Hemodialysis
1.3.2 Home Hemodialysis
1.4 Industry Chain

2. Global Hemodialysis Market
2.1 Dialysis Population
2.2 Status Quo
2.3 Hemodialysis Device Market
2.4 Hemodialysis Service Market
2.5 Dialysis Cost
2.6 Development Tendency

3. Chinese Hemodialysis Market
3.1 Status Quo
3.2 Policy Environment
3.3 Competition Pattern
3.4 Market Size
3.5 Market Prospect
3.5.1 Increased Population Accepting Hemodialysis Therapy
3.5.2 Stable Improvement in Dialysis Treatment Rate

4. Import and Export of Hemodialysis Device in China
4.1 Import
4.2 Export

5. Hemodialysis Market Segments
5.1 Dialysis Machines
5.2 Peritoneal Dialysis Machines
5.3 Dialyzers
5.4 Bloodlines
5.5 Hemodialysis Concentrates, Dialysate
5.6 Hemodialysis Machine for Family Use
5.7 Membrane for Hemodialysis

6. Foreign Manufacturers
6.1 Fresenius Medical Care
6.1.1 Profile
6.1.2 Operation
6.1.3 Dialysis Services
6.1.4 Dialysis Products
6.1.5 Development 
6.1.6 Operation in China
6.2 Nikkiso
6.2.1 Profile
6.2.2 Hemodialysis Business
6.2.3 Operation in China
6.3 Baxter International
6.3.1 Profile
6.3.2 Hemodialysis Business
6.3.3 Operation in China
6.4 Gambro
6.4.1 Profile
6.4.2 Operation
6.4.3 Development Tendency
6.4.4 Operation in China
6.5 Asahi Kasei Corporation
6.5.1 Profile
6.5.2 Hemodialysis Business
6.5.3 Development Tendency
6.5.4 Operation in China
6.6 Nipro
6.6.1 Profile
6.6.2 Operation in China
6.6.3 Development in China
6.7 B. Braun
6.7.1 Profile
6.7.2 Hemodialysis Business
6.7.3 Development in China
6.8 Nxstage
6.8.1 Profile
6.8.2 Operation
6.8.3 Home Hemodialysis Business

7. Domestic Manufacturers
7.1 Shandong Weigao Group Medical Polymer Company Limited
7.1.1 Profile
7.1.2 Operation
7.1.3 Hemodialysis Business
7.1.4 Development Prospect 
7.2 Guangzhou Jihua Medical Apparatus and Instruments
7.2.1 Profile
7.2.2 Hemodialysis Business
7.3 Bain Medical Equipment (Guangzhou)
7.3.1 Profile
7.3.2 Operation
7.4 Beijing United Jie Ran Bio-Tech
7.4.1 Profile
7.4.2 Operation
7.5 Jiangsu Lengthen Life Science and Technology
7.5.1 Profile
7.5.2 Operation
7.5.3 Development Prospect 
7.6 Guangzhou Koncen BioScience
7.6.1 Profile
7.6.2 Operation
Advantage and Disadvantage of In-center Hemodialysis
Advantage and Disadvantage of Home Hemodialysis
Hemodialysis Industry Chain
Global Renal Dialysis Population, 1990-2010
Distribution of Dialysis Patients Worldwide, 2010
Competition Pattern of Global Hemodialysis Device Market, 2010
Competition Pattern of Global Hemodialysis Machine Market, 2010
Competition Pattern of Global Peritoneal Dialysis Machine Market, 2010
Number of Patients with End-stage Renal Disease (ESRD) Worldwide by Therapy, 2010
Distribution of Global Dialysis Service Providers, 2010
Dialysis Patients of Global Top 5 Dialysis Service Providers, 2010
Key Hemodialysis Service Providers and Their Dialysis Patients by Region, 2010
Per Capita Dialysis Cost of Some Countries, 2010
Trade Deficit of Hemodialysis Device in China, 2007-2011
Market Shares of Domestic Manufacturers and Foreign Manufacturers in Hemodialysis Market by Sales Value, 2011
Distribution of Hemodialysis Device Manufacturers by Region, 2011
Market Size of Hemodialysis in China, 2011
Positive Correlation between ESRD Patients/Million Population and Per Capita GDP
Import Value and YoY Growth Rate of Hemodialysis Device in China, 2005-2011
Import Volume and YoY Growth Rate of Hemodialysis Device in China, 2008-2011
Import Origin of Hemodialysis Device of China by Value, 2010-2011
Average Price of Import Hemodialysis Device of China by Origin, 2010-2011
Import Value and Proportion of Hemodialysis Device in China by Province/City, 2010-2011
Top 10 Hemodialysis Device Importers by Value, Jan.-Aug. 2010
Export Value and YoY Growth Rate of Hemodialysis Device in China, 2007-2011
Export Volume and YoY Growth Rate of Hemodialysis Device in China, 2008-2011
Export Destination of Hemodialysis Device of China by Value, 2010-2011
Export Value and Proportion of Hemodialysis Device in China by Province/City, 2010-2011
Prices of Common Home-made and Import Dialysers, 2011
Latest Small-Sized Hemodialysis Machines
Five Branches of Fresenius Group
Net Revenue and Operating Income of Fresenius Medical Care, 2006-2011
Net Revenue Breakdown of Fresenius Medical Care by Product, 2009-2011
Net Revenue Breakdown of Fresenius Medical Care by Region, 2009-2011
Revenue and YoY Growth Rate of Dialysis Services of Fresenius Medical Care, 2007-2011
Net Revenue Breakdown of Dialysis Services of Fresenius Medical Care by Region, 2009-2010
Revenue and YoY Growth Rate of Dialysis Products of Fresenius Medical Care, 2007-2011
Net Revenue Breakdown of Dialysis Products of Fresenius Medical Care by Region, 2009-2010
Net Sales Proportion of Industrial Sector and Medical Sector under Nikkiso, FY2009-FY2011
Net Sales and YoY Growth Rate of Medical Sector under Nikkiso, FY2007-FY2011
Overseas Net Sales Breakdown of Medical Sector under Nikkiso by Region, FY2009-FY2011
Net Sales and YoY Growth Rate of Nikkiso in Asia, FY2009-FY2011
Three Business Sectors of Baxter International Worldwide
Net Sales Breakdown of Baxter by Business, 2008-2011
Net Sales Breakdown of Baxter by Region, 2010-2011
Net Sales of Baxter from PD and HD Businesses, 2008-2010
Net Sales and EBITDA of Gambro, 2007-2011
Nine Operating Companies of Asahi Kasei Corporation and Their Main Businesses
Net Sales Proportion of Health Care Division of Asahi Kasei Corporation, FY2009-FY2011
Net Sales and Operating Income of Health Care Division of Asahi Kasei Corporation, FY2007-FY2011
Operating Revenue and Operating Income of Asahi Kasei Medical (Hangzhou), 2007-2009
Hemodialysis Products of Nipro (Shanghai)
Operating Revenue and Total Profit of Nipro (Shanghai), 2007-2009
Four Business Divisions of B. Braun and Their Major Businesses
Sales Breakdown of B. Braun by Division, 2009-2010
Sales of B. Braun Avitum Division, 2008-2010
Main Business Divisions of NxStage and Their Major Businesses 
Revenue and Gross Profit of NxStage, 2008-2010
Revenue Breakdown of NxStage by Division, 2008-2010
Revenue and Gross Profit of Home Hemodialysis Division of Nxstage, 2008-2010
Sales Revenue and Service Revenue of Home Hemodialysis Business of Nxstage, 2008-2010
Products of Weigao Group
Revenue and Profit of Weigao Group, 2006-H1 2011
Revenue Breakdown of Weigao Group by Product, 2009-H1 2011
Revenue Breakdown of Weigao Group by Region, 2009-H1 2011
Revenue and Growth Rate of Hemodialysis Business of Weigao Group, 2007-H1 2011
Dialyzer Output of Weigao Group, 2008-H1 2011
Hemodialysis Products of Guangzhou Jihua Medical Apparatus and Instruments
Operating Revenue, Total Profit and Gross Margin of Bain Medical Equipment (Guangzhou), 2008-2009
Operating Revenue, Total Profit and Gross Margin of Beijing United Jie Ran Bio-Tech, 2007-2009
Operating Revenue, Total Profit and Gross Margin of Jiangsu Lengthen Life Science and Technology, 2007-2009
Products of Guangzhou Koncen BioScience
Operating Revenue, Total Profit and Gross Margin of Guangzhou Koncen BioScience, 2007-2009

China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010

In 2009, the consumption of oral hypoglyceimic agents (OHAs) in China increased by 15.1% to RMB9.81 billion, accounting for approximately 5% of the world’s total. At present, China is a country with t...

China Contract Research Organization (CRO) Industry Report, 2010-2011

Under the circumstances of increasingly high R&D costs of new drugs worldwide, the contract research organization (CRO) industry has developed rapidly in recent years thanks to its advantages of s...

China Diagnostic Reagent Industry Report, 2011-2012

Diagnostic reagent can be divided into in vitro diagnostic (IVD) reagent and in vivo diagnostic reagent, wherein the former always holds a larger market share in China, accounting for 92.6% in the ove...

China Hospital Industry Development and Investment Report, 2011-2012

Stimulated by market demand and stable national investments, the hospital industry of China has long maintained steady progression in recent years. Up to the end of October 2011, the number of hospita...

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号